De Las Cuevas Carlos, de Leon Jose
Department of Internal Medicine, Dermatology and Psychiatry, University of La Laguna, San Cristóbal de La Laguna, Canary Islands, Spain.
Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
Patient Prefer Adherence. 2020 Oct 9;14:1823-1842. doi: 10.2147/PPA.S242693. eCollection 2020.
Poor adherence to appropriately prescribed medication is a global challenge for psychiatrists.
Measuring adherence is complicated. In our recent three-country naturalistic study including more than 1000 patients and their adherence to multiple medication prescriptions at the same time, patients' self-report of adherence to each specific drug was the only practical option for measuring adherence. Systematic literature reviews provide inconsistent results for sociodemographic, clinical and medication variables as predictors of adherence to psychiatric drugs. Our studies over the last 10 years in relatively stable psychiatric outpatients have shown that some self-reported health beliefs had consistent, strong effects and a better predictive role. Three dimensions of these health beliefs are characteristics of the individual: 1) attitudes toward psychiatric medication such as pharmacophobia (fear of taking drugs or medicines), 2) health locus of control (the belief patients have about who or what agent determines the state of their health), 3) psychological reactance (an emotional reaction in direct contradiction to rules or regulations that threaten or suppress certain freedoms in behavior). They can be measured by the Patient Health Beliefs Questionnaire on Psychiatric Treatment. The attitude toward each specific medication can be measured by the necessity-concern framework and summarized as the presence or absence of skepticism about that drug. After 25 years conducting pharmacokinetic studies in psychiatric drugs, particularly antipsychotics, we have limited understanding of how to use blood levels to predict the effects of non-adherence or to establish it.
Future studies to predict adherence should include the inpatient setting and explore insight. Studying the pharmacokinetics associated with non-adherence in each psychiatric drug is a major challenge. Medication adherence is a complex and dynamic process changing over time in the same patient. Personalizing adherence using psychological or pharmacological variables are in their initial stages.
对合理开具的药物治疗依从性差是精神科医生面临的全球性挑战。
测量依从性很复杂。在我们最近一项涉及三个国家、超过1000名患者且同时观察他们对多种药物处方依从性的自然主义研究中,患者对每种特定药物依从性的自我报告是测量依从性的唯一可行选择。系统的文献综述对于社会人口统计学、临床和药物变量作为精神科药物依从性预测因素的结果并不一致。我们在过去10年对相对稳定的精神科门诊患者的研究表明,一些自我报告的健康信念具有一致、强烈的影响且具有更好的预测作用。这些健康信念的三个维度是个体的特征:1)对精神科药物的态度,如药物恐惧症(害怕服用药物),2)健康控制点(患者对谁或什么因素决定其健康状况的信念),3)心理反抗(与威胁或抑制某些行为自由的规则或规定直接矛盾的情绪反应)。它们可以通过《精神科治疗患者健康信念问卷》来测量。对每种特定药物的态度可以通过必要性 - 关注框架来测量,并总结为对该药物是否存在怀疑。在对精神科药物,特别是抗精神病药物进行了25年的药代动力学研究之后,我们对于如何利用血药浓度来预测不依从的影响或确定不依从情况的了解有限。
未来预测依从性的研究应包括住院患者情况并探索洞察力。研究每种精神科药物不依从相关的药代动力学是一项重大挑战。药物依从性是一个复杂且动态的过程,在同一患者中会随时间变化。利用心理或药物变量进行个性化依从性研究尚处于初始阶段。